|
|
What  offers to Clients:
- Accelerated development to Phase I
- Typically 12 months to CTA
- Flexible solutions tailored to client requirements
- Small molecules or peptide
- Simplified communication
- Single contract
- Dedicated Programme Management support
Benefits of
- Lead candidate to phase I regulatory submission in 12 months
- Reduce conventional timelines
- Reduce cash-burn
- Realise milestones earlier
- Gain competitive advantage through the acceleration of your drug candidate programme
- Focus on adding value to your business through your core competences and reduce the effort spent on auditing, coordinating and managing multiple vendors
|
|
